Boston biotech startup Gingko Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility. The funding comes from previous investors Viking Global, Y Combinator’s Continuity Fund, Cascade Investment, Bill Gates, as well as new investor, General Atlantic. The company previously raised over $154 million, bringing the total up to… Read More
Permalink — http://feedproxy.google.com/~r/Techcrunch/~3/UD73O4lMiec/
URL of source article.
Date — December 14, 2017 12:00 pm
Publish date of source article.
Source — http://feeds.feedburner.com/TechCrunch
URL of RSS feed.
Advertisements
